MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImmunoGen, Inc. - Common Stock (NQ:IMGN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 31.23 (2,500)
Ask (Size) 31.25 (400)
Prev. Close 31.25
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 266,264,274
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024 ↗
Dive into the world of three unstoppable mega-cap stocks leading the charge amidst the bullishness in the market. 
Via InvestorPlace
News headline image
Amicus Therapeutics Stock Sees Improved Relative Strength Rating ↗
In a welcome move, Amicus Therapeutics stock saw its Relative Strength Rating rise from 64 to 78 on Friday. 
Via Investor's Business Daily

Performance

More News

Read More
ImmunoGen Inc. (NASDAQ: IMGN) Near Top of Volume Charts in Thursday Trading
Via Investor Brand Network
News headline image
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗
Via InvestorPlace
News headline image
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024 ↗
Via InvestorPlace
News headline image
Madrigal Pharmaceuticals Stock Shows Rising Relative Strength ↗
Via Investor's Business Daily
News headline image
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall ↗
Via Benzinga
News headline image
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen, Inc.
Via Business Wire
Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
Via Get News
News headline image
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures ↗
Via Benzinga
Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
Via News Direct
Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
Via TheNewswire.com
News headline image
ABBV: This Top Biotech Just Went On A Buying Spree ↗
Via Talk Markets
News headline image
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating ↗
Via Investor's Business Daily
News headline image
7 Dividend Aristocrats That Will Pay You for Years to Come ↗
Via InvestorPlace
News headline image
Ultragenyx Pharm Stock Earns IBD Stock Upgrade With RS Rating Jump To 83 ↗
Via Investor's Business Daily
News headline image
Cassava Sciences Stock Continues Showing Rising Relative Strength ↗
Via Investor's Business Daily
News headline image
Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things' ↗
Via Benzinga
News headline image
Is AbbVie Stock a Buy Now? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
Via Investor's Business Daily
News headline image
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen, Inc.
Via Business Wire
News headline image
3 Biotech Stocks Set for Breakthroughs in 2024 ↗
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals
Via MarketBeat
News headline image
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗
Via Benzinga

Frequently Asked Questions

Is ImmunoGen, Inc. - Common Stock publicly traded?
Yes, ImmunoGen, Inc. - Common Stock is publicly traded.
What exchange does ImmunoGen, Inc. - Common Stock trade on?
ImmunoGen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmunoGen, Inc. - Common Stock?
The ticker symbol for ImmunoGen, Inc. - Common Stock is IMGN on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story